Thus, an active and potent IL-7R response in ‘TT’ individuals may be advantageous to increase CD4+ T cell recovery during suppressive cART, but a disadvantage during untreated HIV infection, as the effect on CD4+ T cells accelerate the viraemia and thereby possibly also disease progression. This evidence concerns the gene IL7R and HIV infectious disease.